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A Novel Technique that Measures Neurotechnique
Peptide Secretion on a Millisecond
Timescale Reveals Rapid Changes in Release
whether a slow synaptic current is due to neuropeptide
secretion. Even more problematic is identifying which
of the many neuropeptides synthesized by a neuron
might be responsible (Bean et al., 1994).
One recent technical advance has been to tag identi-
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United Kingdom fied neuropeptides with green fluorescent protein (Burke
et al., 1997; Lang et al., 1997). Following stimulation,
secretion of neuropeptide is signaled by a loss of cellular
fluorescence. Although powerful, this technique has lim-Summary
ited time resolution and the requirement to add a large
GFP moiety to small neuropeptides means that the ki-Neuropeptides are ubiquitous transmitters that have
been implicated in a wide variety of physiological and netics of release may be distorted. Unfortunately, alter-
native techniques that offer good time resolution, suchpathological conditions, and it is important to under-
stand the processes that control their secretion. We as capacitance tracking, can not identify the types of
transmitters that are released. Having both specificityhave developed a technique that measures neuropep-
tide secretion with high temporal resolution. This and good time resolution is critical to understanding
neurotransmitter exocytosis.method involves placing an electrophysiological “tag”
in a neuropeptide prohormone. The tagged prohor- We considered that a novel way to circumvent these
problems would be to convert the slow peptidergic syn-mone is subsequently expressed together with an ion-
otropic receptor that binds the tag. Because the aptic signal to a rapid ionotropic one. To do this, we
made use of an unusual invertebrate neuropeptide re-neuropeptide of interest and the tag enter the same
population of dense core granules, neuropeptide se- ceptor, the FMRFamide receptor. This receptor, which
was cloned from the snail Helix aspersa (Lingueglia etcretion gives rise to fast, synaptic-like currents. Using
this method, we show that peptide secretion can be al., 1995), is unique among cloned neuropeptide recep-
tors in that it forms a sodium-permeable ion channelmodulated on a millisecond time scale. This technique
could be readily adapted to measure the secretion of (Lingueglia et al., 1995; Cottrell, 1997). The basis of our
approach is to tag a neuropeptide prohormone withany neuropeptide.
the coding sequence for the FMRFamide neuropeptide.
Following expression of the mutant prohormone, exo-Introduction
cytosis results in the cosecretion of both the neuropep-
tide of interest and FMRFamide. To detect FMRFamideNeuropeptides form a large class of neurotransmitters
that are synthesized in all parts of the nervous system secretion, the FMRFamide receptor is also expressed
in the same cell. Because this receptor is ionotropic,(Kupfermann, 1991; Hokfelt et al., 2000) and play impor-
tant functional roles (Baraban et al., 1997; Chemelli et binding of FMRFamide evokes a rapid autaptic re-
sponse, akin to a fast synaptic current. Since neuropep-al., 1999). Their biology clearly distinguishes them from
the classical, fast-acting transmitters such as acetylcho- tides on the same precursor typically enter the same
dense core granules, FMRFamide functions as an “elec-line. For example, while classical transmitters are con-
tained within small vesicles clustered close to the sites trophysiological tag” for the granules that contain the
neuropeptide of interest. Importantly, peptides on differ-of release, neuropeptides are contained within large
dense core granules that are diffusely distributed in the ent precursors can enter different pools of granules,
and thus tagging different peptide precursors could bepresynaptic compartment. Following exocytosis, neuro-
peptides bind to receptors that are generally G protein expected to label different pools of granules (see Arvan
and Castle, 1998).coupled, while classical transmitters can directly gate
postsynaptic ionotropic receptors (Hille, 1991). This technique has several distinct advantages. First,
it is simple to apply and in principal could be adaptedAlthough the biophysical and molecular mechanisms
that regulate the secretion of classical transmitters are to study the secretion of any neuropeptide. Second,
because the detector is fast, it could be used to investi-understood at an impressive level of detail, much less
is known about the regulation of neuropeptide secretion. gate questions about the time course of neuropeptide
secretion. Third, detection does not require the synthe-This discrepancy can be partially attributed to the diffi-
culties in monitoring neuropeptide release. Because the sis of a soluble messenger, so experiments that modify
presynaptic second messenger pathways will not bepostsynaptic actions of neuropeptides tend to be slow
and long lasting, techniques such as quantal analysis, compromised.
which rely on the collection of many postsynaptic
events, cannot be used. In addition, because there are Results
dozens of neuropeptides, but comparatively few neuro-
peptide receptor antagonists, it is difficult to determine To investigate whether the proposed technique (Figure
1A) could measure neuropeptide secretion, we selected
neuropeptide Y (NPY) as a test case. NPY is an abundant* To whom correspondence should be addressed (e-mail: m.whim@
ucl.ac.uk). neuropeptide in the vertebrate nervous system and is
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Figure 1. FMRFamide and Neuropeptide Y Are Colocalized in AtT-20 Cells
(A) Outline of the technique. (i) The NPY prohormone is tagged at the C terminus with the coding sequence for FMRFamide. Note that the
prohormone is not to scale (NPY and FMRFamide are 36 and 4 amino acids in length, respectively). (ii) Expression plasmids coding for the
tagged NPY prohormone, the FMRFamide receptor, and GFP are transfected into AtT-20 cells. (iii) In transfected cells, dense core granules
contain NPY and FMRFamide. Exocytosis is triggered by a step depolarization resulting in the cosecretion of NPY and FMRFamide. The
subsequent activation of the FMRFamide receptor gives rise to a fast autaptic current.
(B) Fluorescent imaging of an AtT-20 cell cotransfected with GFP and the FMRFamide-tagged NPY prohormone. GFP fills the entire cell (upper
panel), while FMRFamide (middle panel) is localized to puncta that cluster at the tips of the processes. Bottom panel shows the merged
image.
(C) A different cell cotransfected with GFP-tagged NPY and the FMRFamide-tagged NPY prohormone. Both NPY-GFP (upper panel) and
FMRFamide (middle panel) are not uniformly distributed but localize to puncta. The yellow spots in the merged image (bottom panel) demonstrate
that NPY-GFP and FMRFamide show a high degree of colocalization. In (B) and (C), each image is a single confocal slice. FMRFamide was
detected using a rabbit anti-FMRFamide antibody and a rhodamine labelled swine anti-rabbit secondary antibody. Scale bar is 10 mm.
implicated in the regulation of many physiological pro- hormone with a sequence encoding KRFMRFG. This tag
was placed at the extreme C-terminal end of the NPYcesses (Wahlestedt and Reis, 1993). As an expression
system, we initially used AtT-20 cells, a cell line derived precursor immediately before the stop codon. The diba-
sic residues (KR) are a consensus cleavage signal thatfrom the anterior pituitary that synthesizes a range of
endogenous neuropeptides. This test system relies on ensures the removal of FMRFG from the precursor poly-
peptide, and the terminal glycine provides an amidationFMRFamide and NPY being synthesized, their entry into
the same population of dense core granules and the signal, converting FMRF to FRMFamide (required for
FMRFamide receptor activation). Thus, translation ofsubsequent detection of FMRFamide secretion by
FMRFamide receptors expressed on the surface of the this precursor should result in the production of two
neuropeptides, FMRFamide and NPY (Figure 1Ai). Thesame cell.
expression plasmid carrying this cDNA was termed
pNPY.Fa.Coexpression and Colocalization of NPY
and FMRFamide To determine whether FMRFamide was actually
made, AtT-20 cells were transfected with pNPY.Fa andTo ensure that NPY and FMRFamide are synthesized
together, we tagged the cDNA encoding the NPY pro- pGFP (to identify the transfected cells), then stained
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with an antibody against FMRFamide. Intense staining tained cells treated identically, but transfected with
all three plasmids. Secretory events could not befor FMRFamide was observed. In contrast to the uniform
cytoplasmic distribution of GFP, FMRFamide immuno- evoked from GFP-positive cells that lacked either the
FMRFamide receptor or the tagged NPY precursor.reactivity was concentrated in puncta that were predom-
inantly localized to the tips of the processes (Figure 1B). However, secretion was consistently observed from sis-
ter cultures that had been transfected with all threeThe distribution of FMRFamide staining is typical of that
seen by endogenous and transfected neuropeptides plasmids (Figures 3A and 3B). Thus, to detect secretory
events, the cell must be transfected with both thethat can be released via the regulated secretory pathway
in AtT-20 cells (Matsuuchi et al., 1988; Jung et al., 1993; FMRFamide receptor and the tagged NPY precursor.
Third, we also tested the possibility that the secretoryChavez and Moore, 1997; Perone et al., 1998).
Because FMRFamide and NPY are present on the events were a nonspecific artifact somehow due to the
overexpression of a neuropeptide. To do this, we madesame precursor, it is expected (see Discussion) that
both neuropeptides will be present in the same granules. an “extended FMRFamide” by adding the coding se-
quence for FMRFamide via a short flexible linker (fourTo examine this assumption, we cotransfected AtT-20
cells with pNPY.Fa and a construct in which enhanced glycine residues), directly to the C-terminal end of NPY.
This construct should make a neuropeptide with theGFP was attached to the C-terminal end of NPY. Previ-
ous work has shown that NPY-GFP enters dense core sequence NPY-GGGGFMRFamide and was termed
pNPY-Fa. However, this neuropeptide is not expectedgranules and can be secreted (Lang et al., 1997). Using
confocal microscopy, the green puncta resulting from to activate the FMRFamide receptor since extended
FMRFamides, such as YGGFMRFamide are over 300the expression of NPY-GFP were extensively colocal-
ized with the red puncta resulting from the FMRFamide times less potent than FMRFamide on the FMRFamide
receptor (Cottrell, 1997). AtT-20 cells that were trans-antibody staining (Figure 1C). These results demon-
strate that FMRFamide is made and it is likely to be in fected with this plasmid showed punctate staining with
the FMRFamide antibody indicating that the extendedthe same granules as NPY.
FMRFamide neuropeptide was made (data not shown).
However, secretory events were never recorded fromRapid Inward Currents that Are Due to the Secretion
green cells that had been transfected with plasmidsof FMRFamide
encoding the “extended FMRFamide,” the FMRFamideWe next examined whether the synthesized FMRFamide
receptor and GFP (Figure 3C). Nevertheless, secretioncould be released and subsequently detected by
was repeatedly observed from control sister culturesFMRFamide receptors expressed on the same cell. AtT-
that had been transfected with the FMRFamide recep-20 cells were transfected with three plasmids, pNPY.Fa,
tor, the FMRFamide-tagged NPY precursor and GFPpFaNaCh (the FMRFamide receptor; FMRFamide so-
(Figure 3C).dium channel; Lingueglia et al., 1995), and pGFP. Whole-
Fourth, we made an AtT-20 cell line that stably ex-cell recordings were then made from GFP-expressing
pressed the FMRFamide-tagged NPY precursor. Whencells. When the membrane potential was stepped from
this cell line was cotransfected with only the FMRFamide280 mV to 120 mV for 3 s, then stepped back to 280 mV,
receptor and GFP, secretory events could be evokednumerous rapid inward currents were observed (Figure
from GFP-positive cells (data not shown).2A). These fast events, which resemble excitatory post-
synaptic currents, required calcium entry through volt-
age-dependent calcium channels since they were GFP Is a Marker for FMRFamide Secretion
Although the above experiments suggest that AtT-20blocked by low concentrations of extracellular cadmium
(100 mM, Figure 2A, n 5 4,) or cobalt (1–3 mM, n 5 4, cells do not contain endogenous FMRFamide receptors,
we tested this directly. In a series of experiments, wedata not shown). Control experiments indicated that 100
mM cadmium did not affect the response to the bath transfected cells with pNPY.Fa, pFaNaCh, and pGFP,
then recorded from a range of cells using the stimulationapplication of 200 nM FMRFamide (2175 6 54 pA versus
2161 6 59 pA, p 5 0.59, n 5 4; control application paradigm described above that elicited secretion. A low
concentration of FMRFamide was then briefly bath ap-versus in the presence of cadmium). The events could
be recorded in both the whole cell and the less disrup- plied. Results from these experiments are shown in Fig-
ures 2C and 2D. Secretory events were never evokedtive perforated patch configuration (Figure 2B). They
are evidently due to the secretion of some transmitter from GFP-negative cells, and bath application of
FMRFamide did not induce a significant current in thesesubstance(s), but do they arise from the release of
FMRFamide or from the secretion of other transmitters cells. In contrast, large inward currents were evoked
in all GFP-positive cells by the application of 200 nMendogenously synthesized by AtT-20 cells? Several
lines of evidence indicate the former. FMRFamide (n 5 10). The variability in the size of the
FMRFamide-induced current (from from 2800 to 22800First, the secretory events were only observed from
GFP-positive cells that had been transfected with the pA) may explain why secretory events could not be
evoked from all GFP-positive cells (see Figure 3). Wethree plasmids coding for the FMRFamide receptor, the
tagged NPY precursor, and GFP. Secretory events were conclude that AtT-20 cells do not express an endoge-
nous ionotropic receptor that recognizes FMRFamide.never elicited from control, i.e., GFP-negative cells (see
below). The cells that have been transfected with pNPY.Fa
will also synthesize NPY in addition to FMRFamide. Al-Second, in a series of experiments, we transfected
cells as above but omitted either the plasmid coding though it is unlikely that the rapid secretory currents
arise from the release of NPY, we tested this possibilityfor the FMRFamide receptor or that coding for the
FMRFamide-tagged NPY precursor. Control dishes con- by bath application of 200 nM NPY to GFP-positive cells
Neuron
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Figure 2. Fast Secretory Currents Arise from the Calcium-Dependent Exocytosis of FMRFamide
(A) AtT-20 cell was stepped from 280 mV to 120 mV for 3 s, repeated five times, with a 20 s interpulse interval. A barrage of fast currents
followed repolarization to 280 mV (top trace). However, stimulation in the presence of 100 mM cadmium (middle trace) failed to evoke the
fast currents (and a large fraction of the voltage-dependent outward current, presumably due to an endogenous calcium-activated potassium
current [Wong et al., 1982], was also eliminated). After washing, repetitive depolarizations again evoked the fast secretory currents (bottom
trace).
(B) In the perforated patch configuration, depolarization from 280 mV to 120 mV for 1 s evoked a burst of rapid secretory currents. Five
superimposed sweeps are shown, the intersweep interval was 20 s. Note the prominent slow inward current following repolarization to 280
mV due to the activation of an endogenous calcium-dependent chloride current (Korn et al., 1991).
(C) FMRFamide but not NPY evokes large inward currents in transfected cells. (i) Application of 200 nM FMRFamide to a cell voltage clamped
at 280 mV induced a large inward current in a cell transfected with the FMRFamide receptor, the tagged NPY precursor and GFP (“GFP1ve”).
Inset shows that secretory events were evoked by 3 s depolarizations from 280 mV to 120 mV. Five superimposed sweeps are shown, the
intersweep interval was 20 s. (ii) Application of FMRFamide to a GFP-negative cell (“GFP–ve”) had no effect (holding potential 280 mV). Inset
shows that no secretory events could be evoked from this cell, using the stimulation protocol described above. (iii) Application of 200 nM
NPY did not induce a change in the holding current (at 280 mV) of a GFP-positive cell cotransfected with the FMRFamide receptor and the
tagged NPY precursor. Inset shows that secretory events could be elicited from this cell using the stimulation paradigm described in (i).
(D) Group data showing that bath application of FMRFamide only evoked significant inward current in GFP-positive cells that had also been
transfected with the FMRFamide receptor. Values are mean 6 SEM (n $ 5 for each treatment).
that had been transfected with pNPY.Fa, pFaNaCh, and subsequently challenged with 200 nM FMRFamide. This
induced a large inward current in each cell tested (FigurepGFP. NPY did not induce any significant current when
the cells were voltage clamped at a holding potential of 2D). We conclude that the rapid secretory events are
not due to the secretion of NPY. This is to be expected280 mV (Figure 2C). As a positive control, each cell was
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Figure 3. Secretory Currents Are Only
Evoked from GFP-Positive Cells that Have
Been Cotransfected with the FMRFamide Re-
ceptor (“FaNaCh”) and the FMRFamide-
Tagged NPY Prohormone (“NPY.Fa”)
(A) No secretory currents could be evoked
from cells that had been transfected with only
the tagged NPY prohormone and GFP.
(B) No secretory currents could be re-
corded from cells transfected with only the
FMRFamide receptor and GFP.
(C) No secretory currents could be evoked
from cells transfected with the FMRFamide
receptor, the “extended FMRFamide” precur-
sor (“NPY-Fa”) and GFP. In all cases (A–C),
secretory currents could be reliably recorded
from GFP-positive cells from sister cultures
that had been cotransfected with the
FMRFamide receptor, the tagged NPY pre-
cursor and GFP. n $ 7 for each treatment.
Variability in the percentage of secreting cells
was typical of that seen between transfec-
tions. To elicit secretion, each cell was held
at 280 mV and stepped to 120 mV for 3 s,
repeated ten times with a 20 s interpulse in-
terval. To enhance secretion, the extracellular
medium contained 5 mM calcium. Traces are
single sweep examples from cells from each
transfection.
since all cloned NPY receptors are G protein–coupled Characteristics of the Neuropeptide
Secretory Eventsreceptors (Blomqvist and Herzog, 1997).
In some cells, the fast secretory currents were superim-
posed on a slowly decaying calcium-dependent chlorideThe Secretory Events Are Blocked
by Amiloride current that was visible as a inward current at 280 mV
(e.g., see Figure 2B). As described by Korn et al. (1991),Because the cloned FMRFamide receptor is blocked by
amiloride (Lingueglia et al., 1995), we would expect that this current was blocked by niflumic acid (data not
shown). We tested whether this current played a role inthis compound would also block the secretory events.
This is what we observed (Figure 4A). Amiloride (100 regulating the release of FMRFamide. Secretion was
evoked by 3 s depolarizing pulses to 120 mV repeatedmM) substantially reduced the fast inward currents. This
concentration blocked z70% of the whole-cell current 5 times every 20 s. This paradigm was repeated three
times separated by 4 min rest periods. Neuropeptideelicited by the application of 200 nM FMRFamide (Fig-
ures 4B and 4C). secretion was then quantified as the summed integral
of the secretory events occurring in each stimulationAlthough AtT-20 cells can release the classical trans-
mitter acetylcholine (Carmeliet and Denef, 1989), the period. 10 mM niflumic acid, a concentration that
blocked the slow inward current did not significantlysecretory events were not blocked by the nicotinic re-
ceptor antagonists hexamethonium and curare and affect the amount of neuropeptide secreted (p 5 0.07,
control versus niflumic acid, n 5 4). Application of vehi-were unaltered in the presence of the muscarinic antag-
onist, atropine (data not shown). cle (0.0001% DMSO) did not affect the amount of neuro-
peptide secreted (p 5 0.54, control secretion versusIn sum, these data indicate that the rapid inward cur-
rents arise from the secretion of FMRFamide and its sub- secretion in the presence of DMSO, n 5 4).
To measure the kinetics of the secretory events, neu-sequent detection by the coexpressed FMRFamide re-
ceptors. In all subsequent experiments, the cellswere trans- ropeptide release was evoked by repeated brief depolar-
izations from 280 to 120 mV at 0.1 Hz. For each cell,fected with expression plasmids for the FMRFamide
receptor, the FMRFamide-tagged NPY precursor and GFP. the duration of depolarization was adjusted empirically
Neuron
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Figure 4. An Antagonist of the FMRFamide
Receptor Reduces Both the Secretory Cur-
rents and the Response to Exogenous
FMRFamide
(A) Secretory currents were evoked in a GFP-
positive cell that had also been transfected
with the FMRFamide receptor and the tagged
NPY prohormone (top trace). The cell was
held at 280 mV and stepped to 120 mV for
500 ms. Five superimposed sweeps are
shown, the intersweep interval was 20 s. In
the presence of 100 mM amiloride, the secre-
tory currents were substantially blocked
(middle trace). Following washout of amilor-
ide, secretory events could again be evoked
(lower trace).
(B) Bath application of 200 nM FMRFamide
evoked an inward current in a GFP-posi-
tive cell that had been transfected with
the FMRFamide receptor and the tagged
NPY precursor (top trace). The response to
FMRFamide was substantially reduced in the
presence of 100 mM amiloride (middle trace).
Following washout of amiloride, the response
to FMRFamide showed a partial recovery
(bottom trace). The cell was held at 280 mV
during the period of FMRFamide application.
Because the actions of amiloride are voltage
dependent (McNicholas and Canessa, 1997),
each drug application was preceded by a se-
ries of voltage steps as in (A) (not shown).
(C) Group data showing that 100 mM amiloride
significantly (p 5 0.026; amiloride versus
wash) reduced the inward current evoked by
the application of 200 nM FMRFamide. Val-
ues are mean 6 SEM (n 5 4).
to evoke individual release events that rose and decayed decay (Figure 5D), suggesting that secretion does not
arise from imperfectly clamped regions of the cell.smoothly. In practice, the duration of depolarization var-
ied from 400 ms to 2 s between experiments. Since there
was no difference in the amplitude, rise time or decay Neuropeptide Release Is Frequency Dependent
Because the preceding experiments used long depolar-time constant of events in the presence or absence of
10 mM niflumic acid, the data was combined (p 5 0.14, izing pulses to induce neuropeptide secretion, we next
determined whether more physiological stimuli were0.28, 0.10, respectively). The individual events varied in
amplitude (2248 6 18.7 pA, mean 6 SEM, n 5 236 also effective in evoking release. When the duration of
the stimulating pulses was reduced to 50 ms, secretoryevents from nine cells; Figures 5A and 5B). This distribu-
tion could arise from a number of sources, including events could still be evoked but these were only loosely
coupled to individual depolarizations (i.e., many pulsesvariations in the levels of neuropeptide within individual
granules or variation in receptor levels (or location). Pre- failed to elicit secretion and the duration between the
end of the stimulus and the event was variable). Veryliminary evidence (data not shown) using an epitope-
tagged version of the FMRFamide receptor (Coscoy et little secretion was typically observed during a train of
50 depolarizations at a frequency of 0.3 Hz. However,al., 1998) indicates that the transfected receptor is
evenly distributed, suggesting that the variability does increasing the stimulation frequency to 3 Hz led to a
large increase in the number of secretory events (Figuresnot arise from marked heterogeneity in receptor loca-
tion. The 10%–90% rise time (Figure 5C, 4.2 6 0.18 ms, 6A and 6B). Furthermore, when the number of release
events is expressed as a proportion of the total, themean 6 SEM, n 5 236) and the decay time constants
(Figure 5D, 16.4 6 0.88 ms, mean 6 SEM, n 5 236) probability of neuropeptide secretion is seen to be effec-
tively zero for the first eight depolarizations (Figure 6C).were much faster than those from “typical” peptidergic
synapses. They are comparable to the values measured Neuropeptide secretion could also be evoked by
much briefer depolarizations in the whole-cell configura-from synaptic currents arising from the release of classi-
cal transmitters. There was a poor correlation between tion, providing that the stimulation frequency was in-
creased. For example, secretion could be evoked by 10the amplitude of the events and the time constant of
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ms depolarizations at a stimulation frequency of 16 Hz
(data not shown). In perforated patch recordings, the
stimulation threshold for secretion was lower (Figure
6D), although it was still frequency dependent (data not
shown).
Peptide Secretion from Chromaffin Cells
To examine whether the FMRFamide-tagging technique
could also monitor secretion of peptide from primary
neuroendocrine cells, we selected rat adrenal chromaf-
fin cells. These cells have the advantage that they en-
dogenously make NPY (Varndell et al., 1984) and thus
allowed us to test whether the technique could measure
the secretion of a native neuropeptide. Isolated cells
were transfected with the plasmids encoding the
FMRFamide-tagged NPY precursor and GFP, then
stained with the anti-FMRFamide antibody. While the
GFP-derived fluorescence was distributed throughout
the cell, FMRFamide immunoreactivity was punctate
(Figure 7A), often in a peripheral ring. When the cells
were cotransfected with pNPY.Fa and pNPY-GFP, the
green punctate fluorescence deriving from NPY-GFP
colocalized with the red puncta resulting from the ex-
pression of FMRFamide (data not shown). Thus, chro-
maffin cells can synthesize FMRFamide.
We then examined whether FMRFamide secretion
could be monitored from chromaffin cells that had
been transfected with the FMRFamide receptor, the
FMRFamide-tagged NPY precursor and GFP. In these
experiments, the pipette solution was designed to sup-
press potassium currents. When GFP-positive cells
were held at 280 mV, then briefly depolarized, rapid
secretory events were frequently observed upon repo-
larization to 280 mV. Secretory events could be evoked
by a train of 10 ms depolarizations at a frequency of 3
Hz (Figure 7B) and had a similar time course to those
previously observed in AtT-20 cells. Again, events were
not closely coupled to individual depolarizations. A vari-
ety of experiments indicated that these secretory events
were due to the release of FMRFamide. First, they were
blocked in the presence of amiloride (Figure 7C), an
antagonist of the FMRFamide receptor, at concentra-
tions that did not affect the calcium current (Figure 7C).
Second, exogenous application of FMRFamide only
evoked an inward current in GFP-positive cells (Figures
7D and 7E) and secretory events could also only be
Figure 5. Characteristics of the Secretory Events evoked from GFP-positive cells (n 5 27). They were
(A) Secretion was evoked from a GFP-positive cell that had also never observed in GFP-negative cells (n 5 13).
been transfected with the FMRFamide receptor and the tagged
prohormone. FMRFamide release was evoked with a 1 s depolariza-
Short-Term Facilitation of Neuropeptide Secretiontion from 280 mV to 120 mV at a frequency of 0.1 Hz. Shown are
The secretion of classical transmitters can be modulatedten postdepolarization sweeps, offset for clarity. The traces are not
over both the short and long term (Zucker, 1999).sequential and did not occur isochronally following the depolariza-
tion but illustrate the variability in amplitude seen within a typical Whether similar changes can occur in the secretion of
experiment. neuropeptides is not known. To investigate this possibil-
(B) Amplitude distribution of events of the type shown in (A). Only ity and to test the utility of the present technique in
events with a smooth rising phase and a decay phase that could
monitoring rapid changes in neuropeptide secretion, webe fit with a single exponential were included (n 5 236 events from
evoked a small amount of secretion from transfectednine cells).
AtT-20 cells with a depolarizing pulse then applied a(C and D) 10%–90% rise time (C) and decay time (D) constants of
the events from the data set shown in (B). second depolarization at a varying time after the first
(Figure 8A). Secretion was measured by integrating over
an 11 s time window (illustrated by the bars in Figure
8A), then expressed as a percentage of the total amount
secreted per cell. The extracellular medium contained
Neuron
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Figure 6. Secretion of FMRFamide Is Frequency Dependent
(A) A GFP-positive cell that had been cotransfected with the FMRFamide receptor and the tagged NPY precursor was depolarized from 280
mV to 120 mV for 50 ms. Fifty such depolarizations were applied at either 0.3, 1, or 3 Hz. The shift in holding current at 1 and 3 Hz was due
to the activation of an endogenous calcium-dependent chloride current. All traces are from the same cell.
(B) Group data from several experiments of the type shown in (A). Secretion was expressed as the percent of total number of postdepolarization
sweeps (each lasting 140 ms) that contained secretory events. Stimulation at 3 Hz evoked significantly more peptide secretion than at 0.3 or
1 Hz (p 5 0.001; 0.002, respectively). Values are mean 6 SEM (n 5 4).
(C) Peptide secretion was evoked by a train of 50 depolarizations at a frequency of 3 Hz as in (A). For the first eight depolarizations, the
probability of peptide secretion was effectively zero. Subsequent depolarizations were equally effective at triggering peptide secretion. Data
is taken from (B).
(D) Secretion of FMRFamide can be evoked by brief (10 ms) depolarizations from 280 mV to 120 mV. The recording was made in the perforated
patch configuration and the cell was stimulated with a train of 50 depolarizations at 2 Hz. The first six depolarizations are shown.
10 mM niflumic acid to block any contaminating calcium- and interpulse interval was not linear and a significant
facilitation was observed with a 60 ms interpulse intervaldependent chloride current. This method will tend to
underestimate the amount of facilitation at short in- (p 5 0.004, 6 s versus 60 ms interpulse intervals, n 5
5, Figure 8B). This was not due to a facilitation of un-terpulse intervals, but because secretion did not occur in
response to single brief depolarizations, more traditional blocked calcium-dependent chloride current because
similar experiments using control, nontransfected cellsmethods of measuring facilitation (e.g., as the ratio of
secretion evoked by two pulses) could not be used. in the presence of niflumic acid showed no difference
in the integral of inward current over the same timeHowever, the relationship between peptide secretion
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Figure 7. Peptide Secretion Can Be Monitored from Chromaffin Cells
(A) A rat chromaffin cell cotransfected with GFP and the FMRFamide-tagged NPY prohormone. GFP (green) fills the entire cell, while FMRFamide
(red) is localized to puncta. FMRFamide was detected as described in Figure 1C. The image is a compression of 27 confocal slices through
the cell. Scale bar is 5 mm.
(B) Perforated patch recording from a GFP-positive chromaffin cell that had also been transfected with the FMRFamide receptor and the
tagged NPY prohormone. Following a 10 ms depolarization to 0 mV from a holding potential of 280 mV, fast secretory currents are evident.
Fifty depolarizations were applied at a frequency of 3 Hz, and ten selected sweeps are shown. Pipette solution was designed to suppress
potassium currents. Note that the first step did not evoke a secretory current, instead the largest event followed the 47th depolarization. The
reduction in the inward current was activity dependent and reversible.
(C) Secretory currents evoked in a GFP-positive cell (cotransfected with the FMRFamide receptor and the tagged NPY prohormone) were
reversibly suppressed by 100 mM amiloride. The cell was held at 280 mV in the whole-cell configuration and stepped to 0 mV for 20 ms at
a frequency of 3 Hz. Thirty superimposed sweeps are shown.
(D) FMRFamide evokes inward current only in GFP-positive cells that have been cotransfected with the FMRFamide receptor. Whole-cell
recording from a GFP-positive (“GFP1ve”) and a GFP-negative cell (“GFP-ve”) from the same culture that had been transfected with the
FMRFamide receptor, the FMRFamide-tagged NPY prohormone and GFP. The holding potential was 280 mV.
(E) Group data from experiments of the type illustrated in (D). Values are mean 6 SEM (n 5 6).
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Figure 8. Short-Term Facilitation of Peptide
Secretion
(A) A recording from a GFP-positive AtT-20
cell that had also been cotransfected with
the FMRFamide receptor and the tagged NPY
prohormone. Two 1 s depolarizing pulses
from 280 mV to 120 mV were applied, sepa-
rated by a variable interpulse interval. Reduc-
ing the interpulse interval from 6 s to 60 ms
produced a large increase in the amount of
neuropeptide secreted. The extracellular so-
lution contained 10 mM niflumic acid to block
the endogenous calcium-dependent chloride
current.
(B) Group data from five experiments of the
type shown in (A). Secretion was quantified as
the integral of the inward secretory currents
during an 11 s window (as indicated by the
bars in [A] for each interpulse interval). Sym-
bols are mean 6 SEM.
windows (p 5 0.7, 6 s versus 60 ms interpulse intervals, Cottrell and colleagues has shown that the C2 neuron
from the snail Helix expresses a FMRFamide receptorn 5 5). Evidently peptide secretion can be modulated
on a brief timescale. that is ionotropic (for review, see Cottrell, 1997). Applica-
tion of FMRFamide to outside-out membrane patches
of C2 induces an inward current even when G proteinDiscussion
activation is prevented and activation of the current oc-
curs rapidly (Green et al., 1994). Recently, a HelixWe have described a novel technique that can be used
to monitor the secretion of neuropeptides on a time FMRFamide receptor, with similar characteristics was
cloned and expressed in oocytes (Lingueglia et al.,scale that is several orders of magnitude faster than
previous methods. It relies on the addition of an electro- 1995). This receptor is unique: it is the only cloned neuro-
peptide receptor that is ionotropic.physiological “tag” (FMRFamide) to the prohormone
containing the neuropeptide of interest and the subse-
quent detection of secretion by the activation of a recep- Some Practical Considerations
As a test of this approach, a cDNA encoding NPY wastor that binds this tag (the FMRFamide receptor). Be-
cause many cell lines and primary cells can be tagged with FMRFamide. Depolarization of AtT-20 cells
that had been transfected with the tagged NPY prohor-transfected, it is anticipated that the technique could
be used to study the secretion of peptide transmitters mone and the FMRFamide receptor elicited rapid inward
currents that were due to the secretion of FMRFamide.from cells in which they are natively synthesized.
The strategy relies upon the use of an unusual neuro- This conclusion was based on numerous lines of evi-
dence. The secretory currents required expression ofpeptide receptor that binds FMRFamide. This neuropep-
tide was first sequenced from molluscs (Price and both the tagged prohormone and the FMRFamide re-
ceptor and were blocked by an antagonist of theGreenberg, 1977) and is an important modulator of neu-
ronal excitability in invertebrates. Although the actions FMRFamide receptor. They were not due to the se-
cretion of NPY since this peptide did not evoke anyof FMRFamide are often mediated by second messen-
gers (Piomelli et al., 1987; Nelson et al., 1998), work by membrane current. Although AtT-20 cells can synthesize
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acetylcholine (Carmeliet and Denef, 1989), they were FMRFamide, they express the transfected receptor.
unaffected by acetylcholine receptor antagonists. Whether there is a vertebrate homolog of the ionotro-
While secretion of FMRFamide can be readily de- pic FMRFamide receptor is not known; while several
tected from both AtT-20 and chromaffin cells using this FMRFamide-like neuropeptides are found in vertebrates
technique, several practical aspects need to be consid- (Yang et al., 1985; Perry et al., 1997), these are extended
ered before transferring this approach to other neuro- versions of FMRFamide. Lengthened peptides do not acti-
peptides. vate the Helix receptor (Lingueglia et al., 1995; Cottrell,
First, the FMRFamide tag needs to be correctly syn- 1997). Thus, it is unlikely that any endogenously synthe-
thesized. Dibasic residues flanking the FMRFG se- sized peptides will activate the heterologously expressed
quence acted as consensus sites ensuring the neuro- receptor and suggests that vertebrate cells will provide
peptide was cleaved from the prohormone, and the a basally silent expression system. Also helpful is the
terminal glycine residue directed amidation. In the case low calcium permeability of the FMRFamide receptor.
of the NPY prohormone, the FMRFamide tag was placed This avoids the possible complication of calcium entry
at the carboxyl terminus of the prohormone, although during receptor activation triggering further secretion
there is no a priori reason why other positions would (e.g., Hollins and Ikeda, 1997). Finally, both AtT-20 and
not work. Ideally, the FMRFamide sequence would have chromaffin cells are small and readily voltage clamped.
been fused directly to the C terminus of NPY. However, Application of this technique to neurons, which grow
the sequence requirements for binding to the FMRFam- extensive processes in culture, would probably require
ide receptor are such that even minor changes in length that they be maintained in microislands to promote the
are not well tolerated (Cottrell, 1997). formation of autaptic synaptic connections (this would
Second, FMRFamide must enter the same dense core also reduce the potential problem of FMRFamide recep-
granules as the neuropeptide of interest. Neuropeptides tors being targeted to specific regions of the cell).
on the same precursor can enter the same dense core
granules, and a variety of signals within individual neuro- Detection of Neuropeptide Release Is Fast,
peptide precursors determine the processing and sort- but the Exocytotic Process Is Slow
ing of the resulting neuropeptides (for review, see Hal- The present work raises a number of issues that are
ban and Irminger, 1994; Arvan and Castle, 1998). Thus, pertinent to the regulation of neuropeptide secretion.
the punctate staining seen with a FMRFamide antibody The rise time of the secretory events was z4 ms, which
colocalized with the punctate fluorescence of GFP is comparable to that of classical synaptic currents, and
tagged NPY. Lang and coworkers have previously puts an upper time limit on the escape of neuropeptide
shown that NPY-GFP enters dense core granules in from granules that have fused with the membrane. Be-
PC12 cells (Lang et al., 1997). While this indicates that cause the cloned FMRFamide receptor does not exhibit
NPY and FMRFamide are likely to be in the same marked desensitization (Cottrell, 1997), it is likely that
granules, more complicated processing scenarios are the decay phase is set either by loss of peptide from
known. For example, peptides on the egg-laying hor- the sites of detection or decay of the secretory process
mone precursor of Aplysia can be sorted into two popu-
itself. Because the secretory events were not tightly
lations of granules (Fisher et al., 1988). However, this
coupled to individual depolarizations this suggests that
may be a special case due to early cleavage in the Golgi
the peptide containing granules are not located close
rather than in immature secretory granules. Cleavage in
to the “presynaptic” calcium channels. This contraststhe latter compartment is characteristic of neuropep-
with the secretion of classical transmitters where thetides, which undergo regulated secretion. While AtT-20
transmitter-containing vesicles are functionally associ-cells do not contain endogenous NPY, they will effi-
ated with presynaptic calcium channels (Mochida et al.,ciently process the NPY prohormone (Dickerson et al.,
1996). Instead neuropeptide secretion from AtT-20 and1987). Both NPY and FMRFamide are secreted from
chromaffin cells more closely resembles the release ofAtT-20 cells via the regulated secretory pathway (Dick-
other dense core granule contents in that it is noterson et al., 1987; this work). In contrast, NPY is thought
strongly coupled to calcium entry (Lim et al., 1990;to be made endogenously by chromaffin cells (Varndell
Thomas et al., 1990; Chow et al., 1996).et al., 1984). The ability to place the FMRFamide tag
Perhaps surprisingly, the frequency-dependent re-anywhere in the peptide prohormone means it may be
lease of peptide from the neuroendocrine AtT-20 cellspossible to test whether granules that contain peptides
was similar to the secretion of neuropeptide from pri-from different parts of a complicated prohormone can
mary neurons. Thus, low frequency stimulation is oftenbe differentially released, or whether different popula-
ineffective in releasing neuropeptides and elevated fre-tions of large dense core granules can be released with
quencies or particular patterns of stimulation are moredistinct kinetics.
efficient (Dutton and Dyball, 1979; Whim and Lloyd,Third, the cell type selected needs to correctly cleave
1989; Peng and Horn, 1991; but see Whim et al., 1997).FMRFamide from the neuropeptide precursor. Pro-
Although the present work mainly used long depolariza-cessing of the NPY precursor in AtT-20 cells is mediated
tions to trigger peptide secretion, brief depolarizationsby prohormone convertase 1/3 (PC1/3, Wulff et al., 1993)
could evoke release from both AtT-20 and chromaffinso presumably PC1/3 can also cleave FMRFamide from
cells (and secretion may be more efficient at a physiolog-the NPY precursor. Some flexibility may be possible,
ical temperature).however, since the NPY precursor can also be pro-
Because the FMRFamide-containing dense corecessed by PC2 (Paquet et al., 1996).
granules in AtT-20 cells were largely clustered at the tipsFourth, although AtT-20 and chromaffin cells do
not contain an endogenous receptor that recognizes of the processes and at the sites of cell–cell contacts, we
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cate glass and had resistances of 4–6 MV. When the time courseassume that neuropeptide release occurs predomi-
of synaptic currents was measured, pipette and cell capacitancenantly from these sites. This targeting of the peptide-
was neutralized and the access resistance was compensated (60%–containing granules has been consistently observed
80%), pipette capacitance was also minimized by coating the pipette
with a range of other molecules that enter the regulated with sylgard and currents were sampled at 5 kHz and filtered at 2
secretory pathway in AtT-20 cells (Matsuuchi et al., kHz. In most other experiments, currents were sampled at 2 kHz.
Bath application of drugs was made by switching between gravity-1988; Jung et al., 1993; Chavez and Moore, 1997). Re-
fed reservoirs and current responses were sampled at 20 Hz. Thecent work using the fluorescent dye FM1–43 to label the
success rate of recording secretion from highly GFP-positive AtT-rapidly recycling (presumably cholinergic) vesicles in
20 cells varied from z60%–100% between transfections.AtT-20 cells also labels the tips of the cell processes
Chromaffin Cells
and the sites of cell–cell contact (Kuzhikandathil and Recordings were made as described for AtT-20 cells except that
Oxford, 1999). Since neuropeptide secretion is not whole-cell recordings used a pipette solution containing 100 mM
Cs acetate, 34 mM CsCl, 9.5 mM NaCl, 1 mM MgCl2, 10 mM HEPES,thought to occur from well defined active zones (Lysa-
4 mM MgATP, 0.3 mM NaGTP (pH 7.2 with CsOH). In experimentskowski et al., 1999), it will be interesting to compare the
that used the perforated patch technique, the solution lacked ATPprecise sites of secretion of the two types of transmitter
and GTP. The success rate of recording neuropeptide secretionin these cells.
from GFP-positive chromaffin cells was z40% (10 of 24 cells from
As mentioned earlier, part of the difficulty in studying four separate experiments).
neuropeptide secretion has been that the methods of Transfected cells were identified by GFP fluorescence. Experi-
ments were performed at room temperature (238C to 268C). Datadetection are slow compared to the likely time course
were analyzed using a variety of programs including pClamp8, Nof exocytosis. Thus, rapid changes in peptide secre-
version 4.0 (Dr. S. Traynelis, Emory University), Mini Analysis (Synap-tion have not been described. Using the release of
tosoft, Leonia, NJ) and Microsoft Excel. Values are given as mean 6FMRFamide from AtT-20 cells as a model system, we
SEM. Statistical significance was assessed using a two-tailed Stu-
find that short-term enhancement of peptide secretion dent’s t test.
is apparent when two depolarizations are separated by
60 ms. This indicates that peptide secretion from neuro- Molecular Biology
endocrine cells, just like the secretion of classical trans- To make pFaNaCh, a vector containing the FaNaCh coding se-
quence (kindly provided by Professor Michel Lazdunski and Dr. Ericmitters from neurons, can be modulated on a millisec-
Lingueglia, Universite de Nice, France) was digested with EcoRIond time scale. This encourages us to think that this
and XhoI and the resulting fragment was ligated into pcDNA3.1technique could be useful in addressing a range of ques-
(Invitrogen, Groningen, Holland) cut with the same enzymes.tions that require both specificity and good time reso-
To make pNPY.Fa, a vector containing prepro human NPY (kindly
lution. provided by Dr. Richard Mains, Johns Hopkins University) was used
as a template. Using primer extension PCR, the sequence
KRFMRFG was added to the 39 end of prepro hNPY, immediatelyExperimental Procedures
before the stop codon (Minth et al., 1984). The primers used were
AAG AGG TTC ATG AGG TTC GGA TGA TGG GAA ATG AGA CTTCell Culture
AtT-20/D16v-F2 cells (European Collection of Cell Cultures; Salis- (top strand) and TCC GAA CCT CAT GAA CCT CTT CCA CAT TGC
AGG GTC TTC (bottom strand). A HindIII/XbaI fragment was thenbury, Great Britain) were grown in 200 ml flasks in DMEM/10% FCS
and passaged every 4–5 days. Cells were plated onto 35 mm culture ligated into pcDNA3.1 cut with the same enzymes.
A similar strategy was employed to make pNPY-Fa, except thatdishes and transfected 24 hr later using Lipofectamine Plus (GIBCO-
BRL). Immediately after transfection, the cells were maintained in the sequence GGGGFMRF was added to the carboxy-terminal of
NPY immediately before the glycine residue that provides the amida-DMEM/FCS containing 0.5 mM TTX to reduce spontaneous activity.
The majority of experiments used cells which had been transfected tion signal for NPY. The primers used were GGA GGC GGA GGC
TTC ATG AGG TTC GGA AAA CGA TCC AGC (top strand) and GAAwith 0.2 mg pGFP/0.65 mg pFaNaCh/0.65 mg pNPY.Fa. Other combi-
nations are described in the text. Cells were used for experiments CCT CAT GAA GCC TCC GCC TCC ATA TCT CTG CCT GGT (bottom
strand). A HindIII/XbaI fragment was then ligated into pcDNA3.1 cut24–48 hr following transfection.
Chromaffin cells were isolated from the adrenal medullae of P17 with the same enzymes. Sequencing was performed to ensure that
all constructs were correct.rats as described (Hollins and Ikeda, 1997) with only minor modifica-
tions, and maintained in culture medium (DMEM/10% FCS/50 U The vector containing GFP attached to the C-terminal end of hNPY
was kindly provided by Dr. Thorsten Lang (Max-Planck Institute,ml21 penicillin/50 mg ml21 streptomycin) in poly-l-lysine coated 35
mm culture dishes. Cells were transfected 24–48 hr later in DMEM Heidelberg, FRG).
To identify transfected cells, a vector containing GFP, pQBI25using calcium phosphate (Xia et al., 1996), followed by a 10% glyc-
erol shock for 1–4 min. Cells were typically transfected with 0.53 (Quantum Biotechnologies Inc.), was included in the transfection
mixture.mg pGFP/3.45 mg pFaNaCh/3.45 mg pNPY.Fa. After transfection,
cells were returned to culture medium containing 0.5 mM TTX and A CMV promoter drove expression from all vectors. Plasmid DNA
was prepared using a commercial kit (Qiagen maxi columns) andused 24–72 hr later.
stored at 2208C.
Electrophysiology
AtT-20 Cells Immunofluorescence
Cells were plated onto poly-l-lysine coated coverslips and trans-Whole-cell recordings were made with an Axopatch 200A amplifier
under the control of pClamp6 software (Axon Instruments). The fected 5 hr (AtT-20 cells) or 24 hr (chromaffin cells) later. After 24
hr the cells were fixed with 4% paraformaldehyde in PBS for 25pipette solution contained 120 mM K acetate, 15 mM KCl, 5 mM
NaCl, 10 mM HEPES, 4 mM MgATP, 0.3 mM NaGTP (pH 7.2 with min, then permeabilized in 0.3% triton in PBS for 15 min. Following
a 30 min wash with blocking solution (PBS/10% fetal calf serum/KOH). Cells were continually superfused with extracellular solution
containing 130 mM NaCl, 3 mM KCl, 2 mM CaCl2, 1 mM MgCl2, 10 0.05% triton/0.25% BSA), the coverslips were inverted over a droplet
of blocking solution containing a rabbit anti-FMRFamide antibodymM HEPES, 11 mM glucose (pH 7.3 with NaOH). Voltages were not
corrected for a 7 mV liquid junction potential. A few experiments (Peninsula Laboratories, Inc, Belmont, CA) at a dilution of 1:200.
After an overnight incubation at 48C, the cells were washed inwere made using the perforated patch technique in which the pipette
solution contained 100–300 mg/ml amphotericin B (Sigma) and blocking solution (4 3 15 min), then incubated in a 1:40 dilution of
rhodamine labeled swine anti-rabbit secondary antibody (DAKO,lacked ATP and GTP. Pipettes were pulled from thin walled borosili-
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Cambridge, UK) for 90 min at room temperature. Cells were subse- Diez, M. (2000). Neuropeptides—an overview. Neuropharmacology
39, 1337–1356.quently washed with blocking solution and PBS, then mounted in
Vectashield (Vector Laboratories, Burlingame, CA). Immunofluores- Hollins, B., and Ikeda, S.R. (1997). Heterologous expression of a P2x-
cence was detected with a Leica TCS confocal microscope. purinoceptor in rat chromaffin cells detects vesicular ATP release. J.
Neurophysiol. 78, 3069–3076.
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